PF-Atlas › Drugs › Pirfenidone Oral Tablet

Pirfenidone Oral Tablet

Idiopathic Pulmonary Fibrosis

Clinical trials
2
Developer
Instituto de investigación e innovación biomédica de Cádiz

Overview

Pirfenidone Oral Tablet is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.

Pirfenidone Oral Tablet clinical trials

NCT05118256 (Phase 2)NCT05350371 (Phase 1)

Explore related

All trialsResearch
Medical disclaimer. This page summarizes research about Pirfenidone Oral Tablet for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.